It has been suggested that cancer cells may express variable levels of different PFK-2/FBPase-2 enzymes and modulate their relative kinase and/or bisphosphatase activity according to their temporal and spatial metabolic needs [18]. The gene discussed is FBP2; the disease is cancer.